PETX
Franklin Resources’s Aratana Therapeutics, Inc. PETX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$52K | – | 1594 |
|
|
2019
Q2 | $52K | Buy |
+10,000
| New | +$52K | ﹤0.01% | 1534 |
|
|
2019
Q1 | – | Sell |
-5,528,361
| Closed | -$33.9M | – | 1551 |
|
|
2018
Q4 | $33.9M | Sell |
5,528,361
-453,805
| -8% | -$2.78M | 0.02% | 570 |
|
|
2018
Q3 | $34.9M | Sell |
5,982,166
-25,354
| -0.4% | -$148K | 0.02% | 626 |
|
|
2018
Q2 | $25.5M | Buy |
6,007,520
+38,149
| +0.6% | +$162K | 0.01% | 705 |
|
|
2018
Q1 | $26.3M | Buy |
5,969,371
+28,969
| +0.5% | +$128K | 0.01% | 705 |
|
|
2017
Q4 | $31.2M | Sell |
5,940,402
-149,158
| -2% | -$785K | 0.02% | 677 |
|
|
2017
Q3 | $37.3M | Buy |
6,089,560
+78,251
| +1% | +$480K | 0.02% | 619 |
|
|
2017
Q2 | $43.5M | Buy |
6,011,309
+604,518
| +11% | +$4.37M | 0.02% | 573 |
|
|
2017
Q1 | $28.7M | Buy |
5,406,791
+19,992
| +0.4% | +$106K | 0.01% | 692 |
|
|
2016
Q4 | $38.7M | Sell |
5,386,799
-3,930
| -0.1% | -$28.2K | 0.02% | 596 |
|
|
2016
Q3 | $50.5M | Sell |
5,390,729
-19,462
| -0.4% | -$182K | 0.03% | 519 |
|
|
2016
Q2 | $34.2M | Sell |
5,410,191
-11,358
| -0.2% | -$71.8K | 0.02% | 643 |
|
|
2016
Q1 | $29.9M | Buy |
5,421,549
+1,037,646
| +24% | +$5.73M | 0.02% | 691 |
|
|
2015
Q4 | $24.5M | Buy |
4,383,903
+422,427
| +11% | +$2.36M | 0.01% | 773 |
|
|
2015
Q3 | $33.5M | Buy |
3,961,476
+161,634
| +4% | +$1.37M | 0.02% | 693 |
|
|
2015
Q2 | $57.5M | Buy |
3,799,842
+373,965
| +11% | +$5.65M | 0.03% | 554 |
|
|
2015
Q1 | $54.8M | Buy |
3,425,877
+101,871
| +3% | +$1.63M | 0.02% | 564 |
|
|
2014
Q4 | $59.2M | Sell |
3,324,006
-44,913
| -1% | -$800K | 0.03% | 541 |
|
|
2014
Q3 | $33.8M | Buy |
3,368,919
+723,615
| +27% | +$7.26M | 0.02% | 717 |
|
|
2014
Q2 | $41.3M | Buy |
2,645,304
+1,052,147
| +66% | +$16.4M | 0.02% | 667 |
|
|
2014
Q1 | $29.6M | Buy |
1,593,157
+1,565,305
| +5,620% | +$29.1M | 0.01% | 754 |
|
|
2013
Q4 | $533K | Buy |
+27,852
| New | +$533K | ﹤0.01% | 1389 |
|